Inhalable cardiac targeting platelet biomimetic astragaloside IV derivative nanomedicine for the fibrotic heart repair

Myocardial fibrosis (MF) is a hallmark of adverse cardiac remodeling and a key driver of heart failure in cardiovascular diseases. Currently, the oral administrated drugs used for treating MF still have significant limitations, such as low efficiency of drug delivery to the heart and potential toxicity in long-term use. Inspired by the efficient cardiac delivery characteristics of inhaled drugs, this study developed a platelet-biomimetic nanomedicine PCL, consisted of carbonized Sophorae Flos -derived carbon dots loading with Astragaloside IV derivative (LS102) and followed by coated with the platelet membrane. As a result, compared with intravenous injection, inhaled PCL markedly improved the targeted delivery efficiency of the drug to the fibrotic myocardium, exhibiting an in vivo distribution profile characterized by pulmonary-to-systemic delivery followed by preferential accumulation in the heart. The long-term inhalation treatment regimen showed good efficacy without causing severe organ damage. Moreover, this study revealed that inhalation therapy mainly inhibited endothelial-mesenchymal transition, and reduced collagen deposition and myocardial damage, thus promoting fibrotic heart repair and cardiac function recovery post-MI. This study provides a novel idea for exploring targeted inhalation therapy for MI and proposes promising clinical strategies for the long-term management of MF.

Authors

Institutions

Publication Details

Journal
Journal of Nanobiotechnology
Published
2026-11-13
DOI
https://doi.org/10.1186/s12951-026-05264-7
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Inhalable cardiac targeting platelet biomimetic astragaloside IV derivative nanomedicine for the fibrotic heart repair

Mijia Zhang, Pan Liang, Jiangxue Li, 張舒涵 et al.
2 links
Journal of Nanobiotechnology
Nanoparticle-Based Drug Delivery
article

Inhalable cardiac targeting platelet biomimetic astragaloside IV derivative nanomedicine for the fibrotic heart repair

Mijia Zhang, Pan Liang, Jiangxue Li, 張舒涵, Tao Ye, Li Deng, Chuqiao Luo, Anrui Xiong, Yongzhou Wang
article en

Abstract

Myocardial fibrosis (MF) is a hallmark of adverse cardiac remodeling and a key driver of heart failure in cardiovascular diseases. Currently, the oral administrated drugs used for treating MF still have significant limitations, such as low efficiency of drug delivery to the heart and potential toxicity in long-term use. Inspired by the efficient cardiac delivery characteristics of inhaled drugs, this study developed a platelet-biomimetic nanomedicine PCL, consisted of carbonized Sophorae Flos -derived carbon dots loading with Astragaloside IV derivative (LS102) and followed by coated with the platelet membrane. As a result, compared with intravenous injection, inhaled PCL markedly improved the targeted delivery efficiency of the drug to the fibrotic myocardium, exhibiting an in vivo distribution profile characterized by pulmonary-to-systemic delivery followed by preferential accumulation in the heart. The long-term inhalation treatment regimen showed good efficacy without causing severe organ damage. Moreover, this study revealed that inhalation therapy mainly inhibited endothelial-mesenchymal transition, and reduced collagen deposition and myocardial damage, thus promoting fibrotic heart repair and cardiac function recovery post-MI. This study provides a novel idea for exploring targeted inhalation therapy for MI and proposes promising clinical strategies for the long-term management of MF.

Journal of Nanobiotechnology
Southwest Medical University (CN), Affiliated Hospital of Southwest Medical University (CN)
National Natural Science Foundation of China, Department of Science and Technology of Sichuan Province, Southwest Medical University
Good health and well-being
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon